由解偶联蛋白2显性突变导致的先天性高胰岛素血症的新型低血糖表型
在费城儿童医院1997年至2016年10月诊治的211例二氮嗪反应性先天性高胰岛素血症(HI)患儿中,检出5例(2.4%)携带解偶联蛋白2(UCP2)显性突变,其中3例二氮嗪治疗仅部分有效;携带者在空腹15-20小时及口服葡萄糖后4小时均出现低血糖,且对葡萄糖诱导的低血糖高度敏感。
要点
- UCP2显性突变占二氮嗪反应性HI的2.4%(5/211),均在6月龄前诊断。
- 5例中3例二氮嗪治疗仅部分有效,4个突变中3个为新发突变。
- 携带者空腹15-20小时出现低酮性低血糖,口服葡萄糖后4小时出现症状性低血糖。
核心结论
- 显性UCP2突变是HI的较既往认识更重要的病因,且受累个体对葡萄糖诱导的低血糖高度敏感。
研究设计与样本
- 研究纳入1997年至2016年10月在费城儿童医院就诊的211例二氮嗪反应性HI患儿,进行UCP2突变筛查及表型分析。
主要发现
- 在211例二氮嗪反应性HI患儿中,检出5例(2.4%)携带UCP2突变,均为无关个体。
- 5例均在6月龄前诊断为HI,其中3例二氮嗪治疗仅部分有效。
- 共鉴定出4个独特突变(3个错义突变和1个剪接突变),其中3个为新发突变,1个为既往报道突变。
- 体外功能试验显示UCP2活性下降30%至75%。
- 2例患儿在未服用二氮嗪时,空腹15至20小时后出现低酮性低血糖;4名成人携带者中,空腹24小时后出现类似低血糖趋势。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The rarest genetic form of congenital hyperinsulinism (HI) has been associated with dominant inactivating mutations in uncoupling protein 2 (UCP2), a mitochondrial inner membrane carrier that modulates oxidation of glucose vs amino acids. OBJECTIVE: To evaluate the frequency of UCP2 mutations in children with HI and phenotypic features of this form of HI. DESIGN: We examined 211 children with diazoxide-responsive HI seen at The Children's Hospital of Philadelphia (CHOP) between 1997 and October 2016. SETTING: CHOP Clinical and Translational Research Center. RESULTS: Of 211 cases of diazoxide-responsive HI, we identified 5 unrelated children with UCP2 mutations (5 of 211; 2.4%). All 5 were diagnosed with HI before 6 months of age; diazoxide treatment was only partly effective in 3 of the 5. Among the 5 cases, 4 unique mutations (3 missense and 1 splicing) were identified. Three mutations were novel; 1 was previously reported. In vitro functional assays showed 30% to 75% decrease in UCP2 activity. Two of the children, when not taking diazoxide, developed hypoketotic-hypoglycemia after fasting 15 to 20 hours; a similar trend toward hypoglycemia after fasting 24 hours occurred in 4 adult carriers. In contrast, both children and 2 of the 4 carriers developed symptomatic hypoglycemia 4 hours following oral glucose. Unusual oscillating glucose and insulin responses to oral glucose were seen in both cases and carriers. CONCLUSIONS: These data indicate that dominant UCP2 mutations are a more important cause of HI than has been recognized and that affected individuals are markedly hypersensitive to glucose-induced hypoglycemia.
引用
- Ferrara CT, Boodhansingh KE, Paradies E, et al. Novel Hypoglycemia Phenotype in Congenital Hyperinsulinism Due to Dominant Mutations of Uncoupling Protein 2. J Clin Endocrinol Metab. 2017. PMID: 27967291. doi:10.1210/jc.2016-3164
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。